These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12975936)

  • 1. [Preliminary data on the phenomenon of auto-erythrophagocytosis in vitro; mechanism of formation and interpretation of so-called L E cell].
    CAPPELLI E
    Accad Medica; 1952 Mar; 67(3):159-60. PubMed ID: 12975936
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of leukocyte agglutination by serum from patients with systemic lupus erythematosus: a manifestation of the L.E. cell phenomenon.
    LEE SL
    Blood; 1958 Aug; 13(8):778-88. PubMed ID: 13560577
    [No Abstract]   [Full Text] [Related]  

  • 3. [Production of so-called L.E. phenomenon in vitro with blood serum taken from acute disseminated lupus erythematosus].
    MARMONT A; FUSCO F
    Accad Medica; 1952 Feb; 67(2):57-62. PubMed ID: 12975925
    [No Abstract]   [Full Text] [Related]  

  • 4. The diagnostic significance of a positive L.E.-cell phenomenon.
    HIJMANS W; KIEVITS JH; SCHUIT HR
    Acta Med Scand; 1958 Jul; 161(5):341-5. PubMed ID: 13559006
    [No Abstract]   [Full Text] [Related]  

  • 5. Some factors influencing the formation of L.E. cells; a method for enhancing L.E. cell production.
    ZINKHAM WH; CONLEY CL
    Bull Johns Hopkins Hosp; 1956 Feb; 98(2):102-19. PubMed ID: 13293453
    [No Abstract]   [Full Text] [Related]  

  • 6. [The phenomenon of autoerythrophagocytosis in vitro; comparison with formative mechanism and attempt to interpret the so-called lupus erythematosus cells].
    CAPPELLI E
    Minerva Dermatol; 1952 May; 27(5):108-14. PubMed ID: 12982584
    [No Abstract]   [Full Text] [Related]  

  • 7. [Theoretical bases and experimental studies with human antireticulo-endothelial serum in vitro on the phenomenon of lupus erythematosus in normal subject; considerations on erythematoid disease as a disease of auto-antibodies].
    CAPPELLI E
    Minerva Dermatol; 1952 Oct; 27(10):215-20. PubMed ID: 13024867
    [No Abstract]   [Full Text] [Related]  

  • 8. [Theoretical bases and experimental production in vitro of so-called lupus erythematosus phenomenon, L. E. phenomenon, in blood of normal subjects].
    CAPPELLI E
    Accad Medica; 1953 May; 68(5):131-2. PubMed ID: 13103988
    [No Abstract]   [Full Text] [Related]  

  • 9. [Persistent leukopenia during atabrine therapy of chronic lupus erythematosus].
    VILANOVA X; DE MORAGAS JM
    Bull Soc Fr Dermatol Syphiligr; 1953; 60(1):19-20. PubMed ID: 13066881
    [No Abstract]   [Full Text] [Related]  

  • 10. L. E. cell phenomenon and in vitro-cortisone.
    CORNBLEET T; FLOOD FT
    Urol Cutaneous Rev; 1951 Apr; 55(4):208. PubMed ID: 14836105
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement fixation reactions with DNA and leukocyte material in systemic lupus erythematosus: correlation with the L. E. cell phenomenon and the clinical status.
    PEARSON CM; CRADDOCK CG; SIMMONS NS
    J Lab Clin Med; 1958 Oct; 52(4):580-7. PubMed ID: 13588170
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunoregulatory disturbances in human and murine systemic lupus erythematosus.
    Santoro TJ
    Clin Exp Rheumatol; 1986; 4(2):169-74. PubMed ID: 2426025
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathogenesis of systemic lupus erythematosus.
    Steinberg AD; Klinman DM
    Rheum Dis Clin North Am; 1988 Apr; 14(1):25-41. PubMed ID: 3041491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histological post-mortem examination of the L. E. phenomenon in case of systemic lupus erythematosus; preliminary communication].
    PENDE G
    Arch Maragliano Patol Clin; 1953; 8(6):1595-1609. PubMed ID: 13159555
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathogenesis of systemic lupus erythematosus.
    Schrieber L; Edmonds JP
    Clin Exp Rheumatol; 1986; 4(2):157-60. PubMed ID: 3488156
    [No Abstract]   [Full Text] [Related]  

  • 16. [So-called L.E. phenomenon in lupus erythematosus].
    BARRERAS AREU L; LABOURDETTE JM; BARRIOS ; QUERO R; GARCIA FAES O
    Rev Cubana Pediatr; 1952 Feb; 24(2):82-7. PubMed ID: 14949641
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lupus erythematosus and allergids; general practical and therapeutic consequences].
    GOUGEROT H
    Paris Med; 1950 Feb; 40(5):75-81. PubMed ID: 15430069
    [No Abstract]   [Full Text] [Related]  

  • 18. [Provocation in vitro of the L. E. phenomenon].
    SCERRATO R
    G Ital Dermatol; 1953; 88(5):416-24. PubMed ID: 13128402
    [No Abstract]   [Full Text] [Related]  

  • 19. Damage-associated molecular patterns and their role as initiators of inflammatory and auto-immune signals in systemic lupus erythematosus.
    Álvarez K; Vasquez G
    Int Rev Immunol; 2017 Sep; 36(5):259-270. PubMed ID: 28961019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental approach to the pathogenesis of systemic lupus erythematosus].
    Lambert PH; Creighton D; Goodman R; Bankhurst A; Mischer PA
    J Urol Nephrol (Paris); 1972 Dec; 78(12):973-80. PubMed ID: 4350279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.